Susquehanna International Group
AGL icon

Susquehanna International Group’s Agilon Health AGL Stock Holding History

Susquehanna International Group’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$848K Buy
107,200
+105,856
+7,876% +$1.71M ﹤0.01% 8315
2025
Q4 		$23.2K Sell
1,344
-9,252
-87% -$179K ﹤0.01% 11927
2025
Q3 		$273K Sell
10,596
-5,840
-36% -$221K ﹤0.01% 10329
2025
Q2 		$945K Sell
16,436
-2,228
-12% -$179K ﹤0.01% 7578
2025
Q1 		$2.02M Buy
18,664
+4,112
+28% +$358K ﹤0.01% 5520
2024
Q4 		$691K Sell
14,552
-16,748
-54% -$1.01M ﹤0.01% 7849
2024
Q3 		$3.08M Sell
31,300
-4,996
-14% -$645K ﹤0.01% 4489
2024
Q2 		$5.93M Buy
36,296
+15,428
+74% +$2.2M ﹤0.01% 3177
2024
Q1 		$3.18M Buy
20,868
+14,636
+235% +$2.44M ﹤0.01% 4409
2023
Q4 		$1.96M Sell
6,232
-1,064
-15% -$385K ﹤0.01% 5395
2023
Q3 		$3.24M Sell
7,296
-2,884
-28% -$1.3M ﹤0.01% 4248
2023
Q2 		$4.41M Sell
10,180
-940
-8% -$528K ﹤0.01% 3737
2023
Q1 		$6.6M Buy
11,120
+4,600
+71% +$2.58M ﹤0.01% 3036
2022
Q4 		$2.63M Buy
6,520
+556
+9% +$261K ﹤0.01% 4223
2022
Q3 		$3.49M Buy
5,964
+1,896
+47% +$1.14M ﹤0.01% 3784
2022
Q2 		$2.22M Buy
4,068
+904
+29% +$457K ﹤0.01% 4689
2022
Q1 		$2M Buy
3,164
+360
+13% +$186K ﹤0.01% 5467
2021
Q4 		$1.89M Buy
2,804
+1,580
+129% +$961K ﹤0.01% 5636
2021
Q3 		$802K Sell
1,224
-1,952
-61% -$1.67M ﹤0.01% 8126
2021
Q2 		$3.22M Buy
+3,176
New +$2.78M ﹤0.01% 4861

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Susquehanna International Group's AGL Position: Q1 2026 in Review

Susquehanna International Group reduced its Agilon Health (AGL) stake by 30% in Q1 2026, selling an estimated $79.4K and leaving 11,570 shares worth $91.5K. The position accounts for ﹤0.01% of the portfolio, ranked #12399.

Susquehanna International Group first reported a position in AGL in Q2 2021 and has held it in 17 quarters since. The position peaked at $3.57M in Q1 2024. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Susquehanna International Group held 11,570 shares of Agilon Health worth $91.5K as of Q1 2026.
  • Susquehanna International Group sold 4,913 Agilon Health shares in Q1 2026, an estimated $79.4K.
  • Agilon Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12399 holding.
  • Susquehanna International Group first reported a position in Agilon Health in Q2 2021 and has held it in 17 quarters since.
  • Susquehanna International Group's Agilon Health position peaked at $3.57M in Q1 2024.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.